IP Library Assignment 057541/0257
Patent Assignment
Reel/Frame 057541/0257

Confirmatory License

Recorded: 2021-09-20 Pages: 2
Assignor
DANA-FARBER CANCER INST
Executed: 2019-02-12
Assignee
NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
NIH DIVISION OF EXTRAMURAL INVENTIONS AND TECHNOLOGY RESOURCES (DEITR), 6705 ROCKLEDGE DRIVE, SUITE 310, MSC 7980, BETHESDA, MARYLAND, 20892-7980
Covered Property (1)
Degradation of Cyclin-Dependent Kinase 9 (CDK9) by Conjugation of CDK9 Inhibitors with E3 Ligase Ligand and Methods of Use
Application: 16/094,102 →
Publication: US 2019/0111143
Related Assignments (1)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 2, 2019
From: GRAY, NATHANAEL S.; ZHANG, TINGHU; OLSON, CALLA M.; LIANG, YANKE
To: DANA-FARBER CANCER INSTITUTE, INC.
Reel/Frame 047882/0088 →